Medicine and Dentistry
Liver Transplantation
100%
Hepatocellular Carcinoma
46%
Transplantation
34%
Allograft
34%
Machine Perfusion
32%
Liver Graft
30%
Pancreas Transplantation
22%
Kidney Graft
21%
Overall Survival
20%
Hepatitis C
20%
Surgery
20%
Body Mass Index
17%
Health Care Cost
17%
Cyclosporine
17%
Graft Survival
17%
Disease
16%
Acute Graft Rejection
15%
Kidney Transplantation
14%
Ischemia
14%
Antiviral Therapy
12%
Biliary Atresia
12%
Antivirus Agent
12%
Prostaglandin E1
12%
Delayed Graft Function
12%
Reperfusion Injury
12%
Hepatitis C Virus
12%
Hepatectomy
12%
Aspartate Aminotransferase
11%
Transaminase
11%
Malignant Neoplasm
11%
Bilirubin
10%
Survival Rate
10%
Organ Transplantation
10%
Hazard Ratio
10%
Multivariate Analysis
10%
Tacrolimus
10%
Kidney Preservation
9%
Immunosuppressive Treatment
9%
Heart Death
9%
Hemoglobin A1c
9%
Hepatic Artery Thrombosis
8%
Organ Donor
8%
Injury
8%
Quality of Life
8%
Alanine Aminotransferase
7%
Immunotherapy
7%
Survival Time
7%
Liver Cirrhosis
7%
Model for End-Stage Liver Disease
7%
Liver Disease
7%
Keyphrases
Machine Preservation
18%
Congenital Biliary Atresia
12%
Donor Pool
12%
Hepatocellular Carcinoma
12%
Human Liver
12%
Liver Transplantation
12%
Preservation-reperfusion Injury
11%
Donation after Cardiac Death
8%
Alanine Aminotransferase
8%
Aspartate Aminotransferase
7%
MELD-Na
7%
Preservation Characteristics
7%
United States
7%
Cyclosporine
6%
Neutrophillymphocyte Ratio
6%
Monogenic Dyslipidemia
6%
Young Donors
6%
Jehovah's Witness
6%
Living Donor Liver Transplantation
6%
Waitlist Time
6%
Microsurgical
6%
Hepatic Artery Thrombosis
6%
Intravenous Rituximab
6%
Calculated Panel Reactive Antibody
6%
Body Mass Index
6%
Highly Sensitized Patients
6%
AL Amyloidosis
6%
Advanced Hepatocellular Carcinoma
6%
Right Hepatectomy
6%
Campath
6%
Strategic Policy
6%
FK506
6%
Hypothermic Machine Perfusion
6%
Donor Age
6%
Organ Care System
6%
Prostaglandin E1 (PGE1)
6%
Pulsatile
6%
Liver Allograft
6%
Graft Utilization
6%
Pancreas Graft
6%
COVID-19
6%
Stem Cells
6%
Clinical Time Series
6%
Diverse Populations
6%
Severe Acute Kidney Injury
6%
Steroid-free Immunosuppression
6%
Hepatitis C Virus Recurrence
6%
Failure Analysis
6%
Pediatric Living Donor Liver Transplantation
6%
Donor Evaluation
6%